Squarepoint’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $930K | Sell |
18,277
-16,185
| -47% | -$824K | ﹤0.01% | 1569 |
|
2025
Q1 | $1.55M | Buy |
34,462
+12,780
| +59% | +$576K | ﹤0.01% | 1289 |
|
2024
Q4 | $897K | Buy |
+21,682
| New | +$897K | ﹤0.01% | 1592 |
|
2024
Q3 | – | Sell |
-67,421
| Closed | -$2.31M | – | 2837 |
|
2024
Q2 | $2.31M | Buy |
67,421
+26,154
| +63% | +$894K | ﹤0.01% | 1009 |
|
2024
Q1 | $1.04M | Sell |
41,267
-90,945
| -69% | -$2.28M | ﹤0.01% | 1340 |
|
2023
Q4 | $3.9M | Buy |
132,212
+32,555
| +33% | +$961K | 0.01% | 759 |
|
2023
Q3 | $3.15M | Buy |
99,657
+62,398
| +167% | +$1.97M | 0.01% | 782 |
|
2023
Q2 | $964K | Buy |
+37,259
| New | +$964K | ﹤0.01% | 1272 |
|
2023
Q1 | – | Sell |
-15,117
| Closed | -$295K | – | 2567 |
|
2022
Q4 | $295K | Buy |
+15,117
| New | +$295K | ﹤0.01% | 1712 |
|
2021
Q1 | – | Sell |
-21,441
| Closed | -$374K | – | 2859 |
|
2020
Q4 | $374K | Sell |
21,441
-2,220
| -9% | -$38.7K | ﹤0.01% | 1710 |
|
2020
Q3 | $456K | Sell |
23,661
-4,326
| -15% | -$83.4K | 0.01% | 1413 |
|
2020
Q2 | $545K | Sell |
27,987
-6,879
| -20% | -$134K | 0.01% | 1259 |
|
2020
Q1 | $488K | Buy |
+34,866
| New | +$488K | 0.01% | 1053 |
|